Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cost-effectiveness targeting CLL

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Response to Aviv et al

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prognostic factors of 90-day mortality in patients hospitalised with COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • Andreas Agathangelidis
  • Anastasia Chatzidimitriou
  • Katerina Gemenetzi
  • Veronique Giudicelli
  • Maria Karypidou
  • Karla Plevova
  • Zadie A Davis
  • Xiao-Jie Yan
  • Sabine Jeromin
  • Christof Schneider
  • Lone Bredo Pedersen
  • Renee Tschumper
  • Lesley A Sutton
  • Panagiotis Baliakas
  • Lydia Scarfò
  • Ellen J van Gastel
  • Marine Armand
  • Eugen Tausch
  • Bella Biderman
  • Constance Baer
  • Davide Bagnara
  • Alba Navarro
  • Anne de Septenville
  • Valentina Guido
  • Gerlinde Mitterbauer-Hohendanner
  • Aleksandar Dimovski
  • Christian Brieghel
  • Sarah Lawless
  • Manja Meggendorfer
  • Kamila Stranska
  • Matthias Ritgen
  • Monica Facco
  • Cristina Tresoldi
  • Andrea Visentin
  • Andrea Patriarca
  • Mark Catherwood
  • Lisa Bonello
  • Andrey Sudarikov
  • Katrina Vanura
  • Maria Roumelioti
  • Hana Skuhrova Francova
  • Theodoros Moysiadis
  • Silvio M Veronese
  • Krzysztof Giannopoulos
  • Larry Mansouri
  • Teodora Karan-Djurasevic
  • Raphael Sandaltzopoulos
  • Csaba Bödör
  • Franco Fais
  • Arnon P Kater
  • Irina Panovska-Stavridis
  • Davide Rossi
  • Salem Alshemmari
  • Panagiotis Panagiotidis
  • Paul A Costeas
  • Blanca Espinet
  • Darko Antic
  • Letizia Foroni
  • Marco Montillo
  • Livio Trentin
  • Niki Stavroyianni
  • Gianluca Gaidano
  • Paola Francia di Celle
  • Carsten Utoft Niemann
  • Elías Campo
  • Achilles Anagnostopoulos
  • Christiane Pott
  • Kirsten Fischer
  • Michael Hallek
  • David Graham Oscier
  • Stephan Stilgenbauer
  • Claudia Haferlach
  • Diane F Jelinek
  • Nicholas Chiorazzi
  • Sarka Pospisilova
  • Marie-Paule Lefranc
  • Sofia Kossida
  • Anton W Langerak
  • Chrysoula Belessi
  • Frederic Davi
  • Richard Rosenquist
  • Paolo Ghia
  • Kostas Stamatopoulos
Vis graf over relationer

Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR immunoglobulin stereotypy in CLL has important implications for understanding disease pathophysiology and refining clinical decision-making. Nevertheless, several issues remain open, especially pertaining to the actual frequency of BcR immunoglobulin stereotypy and major subsets, as well as the existence of higher-order connections between individual subsets. To address these issues, we investigated clonotypic IGHV-IGHD-IGHJ gene rearrangements in a series of 29 856 patients with CLL, by far the largest series worldwide. We report that the stereotyped fraction of CLL peaks at 41% of the entire cohort and that all 19 previously identified major subsets retained their relative size and ranking, while 10 new ones emerged; overall, major stereotyped subsets had a cumulative frequency of 13.5%. Higher-level relationships were evident between subsets, particularly for major stereotyped subsets with unmutated IGHV genes (U-CLL), for which close relations with other subsets, termed "satellites," were identified. Satellite subsets accounted for 3% of the entire cohort. These results confirm our previous notion that major subsets can be robustly identified and are consistent in relative size, hence representing distinct disease variants amenable to compartmentalized research with the potential of overcoming the pronounced heterogeneity of CLL. Furthermore, the existence of satellite subsets reveals a novel aspect of repertoire restriction with implications for refined molecular classification of CLL.

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind137
Udgave nummer10
Sider (fra-til)1365-1376
Antal sider12
ISSN0006-4971
DOI
StatusUdgivet - 11 mar. 2021

ID: 62290906